UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 137

Sortiert nach

Haemostatic differences between SARS-CoV-2 PCR-positive and negative patients at the time of hospital admission

PloS one, 2022-04, Vol.17 (4), p.e0267605-e0267605

2022

Volltextzugriff (PDF)

Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?

Annals of oncology, 2014-05, Vol.25 (5), p.921-927

2014

Volltextzugriff (PDF)

Identification of N‐linked glycosylation and putative O‐fucosylation, C‐mannosylation sites in plasma derived ADAMTS13

Journal of thrombosis and haemostasis, 2014-05, Vol.12 (5), p.670-679

2014

Volltextzugriff (PDF)

Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain

Haematologica (Roma), 2011-11, Vol.96 (11), p.1670-1677

2011

Volltextzugriff (PDF)

Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome

Journal of thrombosis and haemostasis, 2006-12, Vol.4 (12), p.2569-2575

2006

Volltextzugriff (PDF)

New therapeutic options for immune thrombocytopenia

Netherlands journal of medicine, 2011-11, Vol.69 (11-12), p.480-485

2011

Volltextzugriff (PDF)

VH1‐69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2009-03, Vol.7 (3), p.421-428

2009

Volltextzugriff (PDF)

Agonist‐induced platelet reactivity correlates with bleeding in haemato‐oncological patients

Vox sanguinis, 2017-11, Vol.112 (8), p.773-779

2017

Volltextzugriff (PDF)

Splenectomy for the treatment of thrombotic thrombocytopenic purpura

British journal of haematology, 2005-09, Vol.130 (5), p.768-776

2005

Volltextzugriff (PDF)

Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment

Journal of thrombosis and haemostasis, 2003-03, Vol.1 (3), p.445-449

2003

Volltextzugriff (PDF)

P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B‐ALL IN ADULTS. A PHASE II HOVON TRIAL

HemaSphere, 2022-06, Vol.6, p.266-267

2022

Volltextzugriff (PDF)

RITUXIMAB MAINTENANCE FOR PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA IN FIRST COMPLETE REMISSION: RESULTS FROM A RANDOMIZED HOVON‐NORDIC LYMPHOMA GROUP PHASE III STUDY

Hematological oncology, 2019-06, Vol.37 (S2), p.79-80

2019

Volltextzugriff (PDF)

Multiple B‐cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type‐1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2006-11, Vol.4 (11), p.2355-2364

2006

Volltextzugriff (PDF)

The observation of bleeding complications in haemato-oncological patients: stringent watching, relevant reporting

Transfusion medicine (Oxford, England), 2012-12, Vol.22 (6), p.426-431

2012

Volltextzugriff (PDF)

The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission

Journal of thrombosis and haemostasis, 2009-06, Vol.7 (6), p.962-969

2009

Volltextzugriff (PDF)

FRETS‐VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2006-03, Vol.4 (3), p.698-699

2006

Volltextzugriff (PDF)

Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome

Journal of neurology, neurosurgery and psychiatry, 2006-01, Vol.77 (1), p.77-83

2006

Volltextzugriff (PDF)

The origin of P-selectin as a circulating plasma protein

Thrombosis and haemostasis, 1997, Vol.77 (6), p.1081

1997

Volltextzugriff (PDF)

Risk factors for cystoid macular oedema in patients with uveitis

Eye (London), 2008-02, Vol.22 (2), p.256-260

2008

Volltextzugriff (PDF)

Endothelial cell activation markers and delayed cerebral ischaemia in patients with subarachnoid haemorrhage

Journal of neurology, neurosurgery and psychiatry, 2006-07, Vol.77 (7), p.863-867

2006

Volltextzugriff (PDF)

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

The New England journal of medicine, 2013-10, Vol.369 (15), p.1406-1415

2013

Volltextzugriff (PDF)

Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis

Stroke (1970), 1997-11, Vol.28 (11), p.2214-2218

1997

Volltextzugriff (PDF)

Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease

Bone marrow transplantation (Basingstoke), 2006-10, Vol.38 (8), p.561-566

2006

Volltextzugriff (PDF)

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

Circulation (New York, N.Y.), 2014-02, Vol.129 (7), p.764-772

2014

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(108)
Science & Technology
(101)
Life Sciences & Biomedicine
(99)
Female
(74)
Biological And Medical Sciences
(70)
Medical Sciences
(66)
Male
(65)
Middle Aged
(61)
Adult
(57)
Aged
(47)
Hematology
(46)
Cardiovascular System & Cardiology
(26)
Peripheral Vascular Disease
(25)
Adolescent
(21)
Hematologic And Hematopoietic Diseases
(16)
Risk Factors
(16)
Von Willebrand Factor - Metabolism
(16)
Aged, 80 And Over
(14)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(14)
Biomarkers - Blood
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Haemostatic differences between SARS-CoV-2 PCR-positive and negative patients at the time of hospital admission

Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?

Identification of N‐linked glycosylation and putative O‐fucosylation, C‐mannosylation sites in plasma derived ADAMTS13

Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain

Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura

Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome

New therapeutic options for immune thrombocytopenia

VH1‐69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura

Agonist‐induced platelet reactivity correlates with bleeding in haemato‐oncological patients

Splenectomy for the treatment of thrombotic thrombocytopenic purpura

Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment

P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B‐ALL IN ADULTS. A PHASE II HOVON TRIAL

RITUXIMAB MAINTENANCE FOR PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA IN FIRST COMPLETE REMISSION: RESULTS FROM A RANDOMIZED HOVON‐NORDIC LYMPHOMA GROUP PHASE III STUDY

Multiple B‐cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type‐1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura

The observation of bleeding complications in haemato-oncological patients: stringent watching, relevant reporting

The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission

FRETS‐VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura

Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome

The origin of P-selectin as a circulating plasma protein

Risk factors for cystoid macular oedema in patients with uveitis

Endothelial cell activation markers and delayed cerebral ischaemia in patients with subarachnoid haemorrhage

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis

Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

Suchergebnisse filtern